STOCK TITAN

Jushi Holdings Inc. (JUSHF) grants director 100,000 stock options

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Jushi Holdings Inc. reported that director Benjamin Cross received a stock option grant covering 100,000 Subordinate Voting Shares on 12/11/2025. The options have an exercise price of $0.5 per share and expire on 12/11/2035, meaning he can buy shares at that price up to that date once the options vest.

The grant was reported as an acquisition of derivative securities, leaving Cross with 100,000 stock options beneficially owned directly after the transaction. The options vest in three equal installments: one-third on 12/11/2026, one-third on 12/11/2027, and one-third on 12/11/2028, conditioned on his continuous service with the company.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cross Benjamin

(Last) (First) (Middle)
C/O JUSHI HOLDINGS INC.
301 YAMATO ROAD, SUITE 3250

(Street)
BOCA RATON FL 33431

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Jushi Holdings Inc. [ JUSH/JUSHF ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $0.5 12/11/2025 A 100,000 (1) 12/11/2035 Subordinate Voting Shares 100,000 $0 100,000 D
Explanation of Responses:
1. 1/3 of the Options will vest on 12/11/2026, 1/3 will vest on 12/11/2027, and 1/3 will vest on 12/11/2028, subject to continuous service.
Remarks:
/s/ Benjamin Cross 12/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Jushi Holdings Inc. (JUSHF) report in this filing?

The filing reports that a director received a stock option grant for 100,000 derivative securities in the form of options to buy Subordinate Voting Shares.

Who received the stock option grant at Jushi Holdings Inc. (JUSHF) and in what capacity?

The stock option grant was received by Benjamin Cross, who is identified in the filing as a Director of Jushi Holdings Inc.

What are the key terms of the Jushi Holdings (JUSHF) director stock option grant?

The grant is a stock option (right to buy) for 100,000 Subordinate Voting Shares with an exercise price of $0.5 per share and an expiration date of 12/11/2035.

How do the Jushi Holdings Inc. (JUSHF) director stock options vest?

The options vest in three equal installments: one-third on 12/11/2026, one-third on 12/11/2027, and one-third on 12/11/2028, subject to continuous service.

How many derivative securities does the Jushi Holdings (JUSHF) director own after this transaction?

After the reported transaction, the director beneficially owns 100,000 stock options as derivative securities, held in direct ownership.

What type of security is involved in this Jushi Holdings Inc. (JUSHF) insider transaction?

The transaction involves a derivative security, specifically a stock option granting the right to buy Subordinate Voting Shares.

Jushi Hldgs

OTC:JUSHF

JUSHF Rankings

JUSHF Latest News

JUSHF Latest SEC Filings

JUSHF Stock Data

130.80M
173.47M
8.31%
6.49%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Boca Raton